Chromosome Analysis for Hematologic Malignancy Test sale cost 820 AED
Breast Metastatic Marker Test sale cost 880 AED Breast Metastatic Marker Test Cost 980 د.إ Original price was: 980 د.إ.880 د.إCurrent price is: 880 د.إ.
VMA Vanillyl Mandelic Acid 24-Hour Urine Test sale cost 820 AED VMA Vanillyl Mandelic Acid 24-Hour Urine Test Cost 910 د.إ Original price was: 910 د.إ.820 د.إCurrent price is: 820 د.إ.
Sale!

Chromosome Analysis for Hematologic Malignancy Test Cost

Original price was: 910 د.إ.Current price is: 820 د.إ.

-10%

Chromosome Analysis for Hematologic Malignancy Test is a critical diagnostic tool used in the medical field to identify and understand various blood cancers, including leukemia, lymphoma, and myeloma. This test examines chromosomes in blood or bone marrow cells to detect abnormalities that may indicate the presence of a hematologic malignancy. Chromosomal abnormalities, such as translocations, deletions, or duplications, play a significant role in the diagnosis, prognosis, and treatment planning of these diseases.

Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques and accuracy, the test provides crucial insights into the genetic makeup of the malignancy. This information is vital for determining the most effective treatment strategy for the patient. The cost of the Chromosome Analysis for Hematologic Malignancy Test at DNA Labs UAE is 820 AED. This investment in one’s health can lead to a more targeted and successful treatment approach, potentially improving patient outcomes in the fight against blood cancers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Chromosome Analysis for Hematologic Malignancy

Test cost: AED 820.0

Test Name: CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY

Test Components: Culture, Robotic Microscopy, Karyotype

Sample Condition: 2-3 mL (1.5 mL min.) heparinized Bone Marrow OR 3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship refrigerated immediately. DO NOT FREEZE. Specimen must reach LPL, New Delhi within 24 hrs. Duly filled Chromosome & FISH Analysis Requisition form (Form 17) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 4 Working days

Method: Culture, Robotic Microscopy, Karyotype

Test type: Cancer

Doctor: Hematologist

Test Department: CYTOGENETICS

Pre Test Information: Duly filled Chromosome & FISH Analysis Requisition form (Form 17) is mandatory.

Introduction

Chromosome analysis for hematologic malignancy, also known as karyotyping or cytogenetic analysis, is a diagnostic test used to detect genetic abnormalities in the chromosomes of cells involved in hematologic malignancies, such as leukemia, lymphoma, or myeloma.

Test Procedure

During the test, a sample of bone marrow, blood, or lymph node tissue is collected from the patient. The cells in the sample are then cultured in a laboratory to allow them to divide and grow. Once an adequate number of cells have been obtained, they are stained and fixed onto slides. The slides are then examined under a microscope, and the chromosomes in the cells are analyzed. This analysis involves examining the size, shape, and banding patterns of the chromosomes. Any abnormalities, such as translocations, deletions, or duplications, can be identified and documented.

Importance of Chromosome Analysis for Hematologic Malignancy

Chromosome abnormalities are commonly found in hematologic malignancies and can provide important information for diagnosis, prognosis, and treatment decisions. For example, certain translocations, such as the Philadelphia chromosome in chronic myeloid leukemia, are associated with specific types of cancer and may require targeted therapies. In addition to karyotyping, other molecular techniques, such as fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR), may be used to further characterize specific genetic abnormalities or mutations. Overall, chromosome analysis for hematologic malignancy is an important tool in the diagnosis and management of these types of cancers, providing valuable information for personalized treatment approaches.

Test Name CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY Test
Components
Price 820.0 AED
Sample Condition 2\u0192??3 mL (1.5 mL min.) heparinized Bone Marrow OR3 mL (2 mL min.) whole blood in 1 Green Top (Sodium Heparin) tube. Ship refrigerated immediately. DO NOT FREEZE. Specimen must reach LPL, New Delhi within 24 hrs. Duly filledChromosome & FISH Analysis Requisition form (Form 17) is mandatory.
Report Delivery Sample Daily by 9 am; Report 4 Working days
Method Culture, Robotic Microscopy, Karyotype
Test type Cancer
Doctor Hematologist
Test Department: CYTOGENETICS
Pre Test Information Duly filledChromosome & FISH Analysis Requisition form (Form 17) is mandatory.
Test Details

Chromosome analysis for hematologic malignancy, also known as karyotyping or cytogenetic analysis, is a diagnostic test used to detect genetic abnormalities in the chromosomes of cells involved in hematologic malignancies, such as leukemia, lymphoma, or myeloma.

During the test, a sample of bone marrow, blood, or lymph node tissue is collected from the patient. The cells in the sample are then cultured in a laboratory to allow them to divide and grow. Once an adequate number of cells have been obtained, they are stained and fixed onto slides.

The slides are then examined under a microscope, and the chromosomes in the cells are analyzed. This analysis involves examining the size, shape, and banding patterns of the chromosomes. Any abnormalities, such as translocations, deletions, or duplications, can be identified and documented.

Chromosome abnormalities are commonly found in hematologic malignancies and can provide important information for diagnosis, prognosis, and treatment decisions. For example, certain translocations, such as the Philadelphia chromosome in chronic myeloid leukemia, are associated with specific types of cancer and may require targeted therapies.

In addition to karyotyping, other molecular techniques, such as fluorescence in situ hybridization (FISH) or polymerase chain reaction (PCR), may be used to further characterize specific genetic abnormalities or mutations.

Overall, chromosome analysis for hematologic malignancy is an important tool in the diagnosis and management of these types of cancers, providing valuable information for personalized treatment approaches.

SKU: TEST-5968 Category:

Related products